{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T14:12:22Z","timestamp":1655388742780},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","interventional.theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.iccl.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,6,21]],"date-time":"2016-06-21T15:07:26Z","timestamp":1466521646000},"page":"331-347","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contemporary Drug-Eluting Stent Platforms"],"prefix":"10.1016","volume":"5","author":[{"given":"Ramon A.","family":"Partida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"Sigwart","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A\u00a0comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMra1210816","article-title":"Drug-eluting coronary-artery stents","volume":"368","author":"Stefanini","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2011.01.015","article-title":"Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials","volume":"150","author":"Cassese","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"Raber","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrcardio.2013.13","article-title":"New concepts in the design of drug-eluting coronary stents","volume":"10","author":"Garg","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jcin.2011.11.002","article-title":"Stent longitudinal integrity bench insights into a clinical problem","volume":"4","author":"Ormiston","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCINTERVENTIONS.113.000621","article-title":"Stent longitudinal strength assessed using point compression: insights from a second-generation, clinically related bench test","volume":"7","author":"Ormiston","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.medengphy.2010.10.009","article-title":"Drug-eluting stents for coronary artery disease: a review","volume":"33","author":"Martin","year":"2011","journal-title":"Med Eng Phys"},{"key":"10.1016\/j.iccl.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jbm.a.34806","article-title":"Coronary drug-eluting stents: from design optimization to newer strategies","volume":"102","author":"Sun","year":"2014","journal-title":"J\u00a0Biomed Mater Res A"},{"key":"10.1016\/j.iccl.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12325-010-0022-9","article-title":"The platinum chromium element stent platform: from alloy, to design, to clinical practice","volume":"27","author":"Menown","year":"2010","journal-title":"Adv Ther"},{"key":"10.1016\/j.iccl.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0735-1097(03)00119-0","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial","volume":"41","author":"Pache","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.tcm.2014.07.004","article-title":"Novel drug-eluting stents for coronary revascularization","volume":"24","author":"Gogas","year":"2014","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1161\/01.CIR.0000148371.53174.05","article-title":"Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation","volume":"110","author":"Takebayashi","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jbiomech.2014.01.006","article-title":"Predicting response to endovascular therapies: dissecting the roles of local lesion complexity, systemic comorbidity, and clinical uncertainty","volume":"47","author":"Kolandaivelu","year":"2014","journal-title":"J\u00a0Biomech"},{"key":"10.1016\/j.iccl.2016.02.003_bib17","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/CIRCULATIONAHA.110.003210","article-title":"Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings","volume":"123","author":"Kolandaivelu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jacc.2005.07.071","article-title":"Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project","volume":"47","author":"Nebeker","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jconrel.2014.05.011","article-title":"Drug-eluting biostable and erodible stents","volume":"193","author":"Huang","year":"2014","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.iccl.2016.02.003_bib22","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1161\/ATVBAHA.107.144220","article-title":"Vascular responses to drug eluting stents: importance of delayed healing","volume":"27","author":"Finn","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.iccl.2016.02.003_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/bmb\/ldt009","article-title":"Coronary stents: historical development, current status and future directions","volume":"106","author":"Iqbal","year":"2013","journal-title":"Br Med Bull"},{"key":"10.1016\/j.iccl.2016.02.003_bib24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2010.06.007","article-title":"Coronary stents: current status","volume":"56","author":"Garg","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib25","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1136\/heartjnl-2012-303522","article-title":"Coronary stents: novel developments","volume":"100","author":"Stefanini","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.iccl.2016.02.003_bib26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.15420\/icr.2011.6.2.134","article-title":"Platinum Chromium Stent Series \u00e2 The TAXUS Element (ION), PROMUS Element and OMEGA Stents","volume":"6","author":"Allocco","year":"2011","journal-title":"Intervent Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.carrev.2009.02.003","article-title":"Drug-eluting stent fracture and acute coronary syndrome","volume":"10","author":"Chhatriwalla","year":"2009","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3346\/jkms.2011.26.1.53","article-title":"Clinical characteristics of coronary drug-eluting stent fracture: insights from a two-center des registry","volume":"26","author":"Park","year":"2011","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.iccl.2016.02.003_bib29","doi-asserted-by":"crossref","first-page":"E251","DOI":"10.1002\/ccd.25423","article-title":"Stent fracture: Insights on mechanisms, treatments, and outcomes from the food and drug administration manufacturer and user facility device experience database","volume":"83","author":"Mamas","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib30","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2009.05.075","article-title":"Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis","volume":"54","author":"Nakazawa","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib31","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.amjcard.2010.06.010","article-title":"Meta-analysis of incidence, clinical characteristics and implications of stent fracture","volume":"106","author":"Chakravarty","year":"2010","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.iccl.2016.02.003_bib32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10439-015-1476-3","article-title":"Structural Mechanics Predictions Relating to Clinical Coronary Stent Fracture in a 5 Year Period in FDA MAUDE Database","volume":"44","author":"Everett","year":"2016","journal-title":"Ann Biomed Eng"},{"key":"10.1016\/j.iccl.2016.02.003_bib33","first-page":"215","article-title":"Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent","volume":"60","author":"Park","year":"2012","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4244\/EIJV8I2A33","article-title":"Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database","volume":"8","author":"Mamas","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2016.02.003_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4244\/EIJV8I2A41","article-title":"Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms","volume":"8","author":"Williams","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2016.02.003_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4244\/EIJV8I2A42","article-title":"Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents","volume":"8","author":"Prabhu","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2016.02.003_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4244\/EIJV8I2A32","article-title":"Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials","volume":"8","author":"Kereiakes","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2016.02.003_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib39","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.iccl.2016.02.003_bib40","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases","volume":"119","author":"van Werkum","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2016.02.003_bib42","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"Stone","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCULATIONAHA.107.762047","article-title":"Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study","volume":"118","author":"Nakazawa","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib44","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1161\/CIRCULATIONAHA.106.687186","article-title":"Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation","volume":"115","author":"Stone","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib45","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacc.2010.05.066","article-title":"Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib46","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","article-title":"Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis","volume":"65","author":"Palmerini","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10016","key":"10.1016\/j.iccl.2016.02.003_bib47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0140-6736(15)00548-6","article-title":"Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial","volume":"387","author":"Sabate","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2016.02.003_bib48","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1\u00a0year results of a randomised controlled trial","volume":"380","author":"Sabate","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2016.02.003_bib49","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jcin.2015.05.026","article-title":"Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy","volume":"8","author":"Kereiakes","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib50","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/ccd.25877","article-title":"Long-term follow-up of the platinum chromium TAXUS element (ION) stent: The PERSEUS Workhorse and Small Vessel Trial Five-Year Results","volume":"86","author":"Kereiakes","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib51","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.amjcard.2010.10.069","article-title":"Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial)","volume":"107","author":"Applegate","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib52","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib53","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.299.16.1903","article-title":"Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial","volume":"299","author":"Stone","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.iccl.2016.02.003_bib54","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jcin.2013.07.009","volume":"6","author":"Gada","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib55","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib56","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","volume":"6","author":"Dangas","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib57","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1056\/NEJMoa1510188","article-title":"Paclitaxel-Eluting versus Everolimus-Eluting Coronary Stents in Diabetes","volume":"373","author":"Kaul","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacc.2009.08.067","article-title":"A\u00a0randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial","volume":"55","author":"Leon","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib59","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcin.2012.12.123","article-title":"The \u201cfinal\u201d 5-year follow-up from the ENDEAVOR IV trial comparing a zotarolimus-eluting stent with a paclitaxel-eluting stent","volume":"6","author":"Kirtane","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib60","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcin.2010.12.014","volume":"4","author":"Kandzari","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jcin.2012.04.008","article-title":"3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents","volume":"5","author":"Maeng","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib62","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2010.03.020","article-title":"2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents","volume":"55","author":"Byrne","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib63","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2010.03.086","volume":"56","author":"Park","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib64","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2010.08.021","article-title":"Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents","volume":"3","author":"Mauri","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib65","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcin.2012.12.125","article-title":"Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents","volume":"6","author":"Kandzari","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib66","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(14)60405-0","article-title":"Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial","volume":"383","author":"Maeng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2016.02.003_bib67","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/eurheartj\/ehu318","article-title":"Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trial","volume":"35","author":"Wijns","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2016.02.003_bib68","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jcin.2009.07.007","article-title":"Clinical and angiographic results with the next-generation resolute stent system: a prospective, multicenter, first-in-human trial","volume":"2","author":"Meredith","year":"2009","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib69","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4244\/EIJV5I6A114","article-title":"Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial","volume":"5","author":"Meredith","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2016.02.003_bib70","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib71","doi-asserted-by":"crossref","first-page":"e002230","DOI":"10.1161\/CIRCINTERVENTIONS.114.002230","article-title":"Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial","volume":"8","author":"Iqbal","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib72","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2012.01.008","article-title":"A\u00a0randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial","volume":"59","author":"von Birgelen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib73","first-page":"266","article-title":"One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial)","volume":"1","author":"Tsuchida","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1016\/j.iccl.2016.02.003_bib74","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib75","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2016.02.003_bib76","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jcin.2015.03.028","volume":"8","author":"Smits","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib77","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.112.104059","article-title":"Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET)","volume":"126","author":"Kimura","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib78","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2016.02.003_bib79","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2011.07.031","article-title":"Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial","volume":"58","author":"Park","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib80","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jcin.2014.02.014","article-title":"Three-year outcomes after revascularization with everolimus- and sirolimus-eluting stents from the SORT OUT IV trial","volume":"7","author":"Jensen","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib81","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2011.06.049","article-title":"Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials","volume":"58","author":"Baber","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib82","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.jacc.2011.02.016","volume":"57","author":"Stone","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib83","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.amjcard.2013.12.011","article-title":"Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial)","volume":"113","author":"Meredith","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"von Birgelen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.iccl.2016.02.003_bib85","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/j.jacc.2014.04.013","volume":"63","author":"Park","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib86","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/eurheartj\/ehs036","article-title":"Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Kalesan","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.iccl.2016.02.003_bib87","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCULATIONAHA.109.906040","volume":"122","author":"Guo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib88","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1161\/01.CIR.0000160363.30639.37","article-title":"Thrombosis modulates arterial drug distribution for drug-eluting stents","volume":"111","author":"Hwang","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2016.02.003_bib89","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2008.07.027","article-title":"Thrombus causes fluctuations in arterial drug delivery from intravascular stents","volume":"131","author":"Balakrishnan","year":"2008","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.iccl.2016.02.003_bib90","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jcin.2014.02.016","article-title":"Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial","volume":"7","author":"Di Lorenzo","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib91","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2012.01.073","article-title":"Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial","volume":"60","author":"Hofma","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib92","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacc.2013.05.022","article-title":"Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis","volume":"62","author":"Palmerini","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib93","doi-asserted-by":"crossref","first-page":"e72895","DOI":"10.1371\/journal.pone.0072895","article-title":"Drug-eluting stents for acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.iccl.2016.02.003_bib94","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.amjcard.2011.07.029","article-title":"Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry)","volume":"108","author":"Green","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib95","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrcardio.2013.15","article-title":"Management of cardiovascular disease in patients with kidney disease","volume":"10","author":"Kahn","year":"2013","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib96","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ccd.23199","article-title":"Impact of renal insufficiency on safety and efficacy of drug-eluting stents compared to bare-metal stents at 6 years","volume":"80","author":"Simsek","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.iccl.2016.02.003_bib97","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.jacc.2011.06.056","article-title":"Safety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database","volume":"58","author":"Tsai","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2016.02.003_bib98","doi-asserted-by":"crossref","first-page":"a1331","DOI":"10.1136\/bmj.a1331","article-title":"Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis","volume":"337","author":"Stettler","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.iccl.2016.02.003_bib99","doi-asserted-by":"crossref","first-page":"e5170","DOI":"10.1136\/bmj.e5170","article-title":"Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials","volume":"345","author":"Bangalore","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.iccl.2016.02.003_bib100","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/ccd.25045","article-title":"Long-term efficacy and safety of Zotarolimus-eluting stent in patients with diabetes mellitus: pooled 5-year results from the ENDEAVOR III and IV trials","volume":"82","author":"Vardi","year":"2013","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745816300190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745816300190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T03:21:37Z","timestamp":1536636097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745816300190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2211745816300190"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2016.02.003","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contemporary Drug-Eluting Stent Platforms","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}